cuomo's plan requires the health department to post tick collection and testing results to health data ny and make the data available to the public, which was not released before.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.3000
.
.
another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict
. and our daily headlines will be delivered to your inbox each morning.
.